<DOC>
	<DOC>NCT01446003</DOC>
	<brief_summary>This study will evaluate the effect of treatment with multiple doses of MK-8457 on systolic blood pressure in participants with mild to moderate hypertension.</brief_summary>
	<brief_title>A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)</brief_title>
	<detailed_description />
	<criteria>If female, must be of nonchildbearing potential If male with female partner(s) of childbearing potential must agree to use a medically acceptable method of contraception during the study and for 90 days after the last dose of study drug Body mass index (BMI) â‰¤35 kg/m^2 Mildtomoderate hypertension requiring treatment with one or more antihypertensive agents Receiving stable treatment for hypertension for at least 8 weeks prior to the start of dosing and continuing therapy for duration of study No clinically significant arrhythmias or clinically significant abnormality on electrocardiogram Nonsmoker and/or has not used nicotine or nicotinecontaining products for at least approximately 6 months Any illness that might confound the results of the study or poses an additional risk History of stroke, chronic seizures, or major neurological disorder Clinically significant endocrine, gastrointestinal, hematological, hepatic, immunological, renal, respiratory, or genitourinary abnormalities or diseases Clinically significant cardiovascular disease or has active angina History of malignant neoplastic disease Taking 325 mg aspirin daily Taking 3 or more medications for the treatment of hypertension Unable to refrain from or anticipates the use of any nonsteroidal antiinflammatory drugs (NSAIDs) Consumes excessive amounts of alcohol and/or coffee, tea, cola, or other caffeinated beverages Has had major surgery, donated or lost 1 unit of blood or participated in another investigational study within 4 weeks Significant multiple and/or severe allergies Regular user of any illicit drugs or has a history of drug (including alcohol) abuse within approximately 2 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>